WEST PHARMACEUTICAL SERVICES, INC. (WST) /

The cash flow of WEST PHARMACEUTICAL SERVICES, INC. over the past 10 years

Chart WEST PHARMACEUTICAL SERVICES, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, WEST PHARMACEUTICAL SERVICES, INC.'s operating cash flow was $754.8M and its capital expenditures $285.9M, leaving free cash flow of $468.9M. Free cash flow was above zero in all 10 years shown. It ranged from $49.2M in fiscal 2016 to $468.9M in fiscal 2025. Capital expenditures were highest in fiscal 2024, at $377M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$754.8M$285.9M$468.9M
2024ended Dec 31, 2024$653.4M$377M$276.4M
2023ended Dec 31, 2023$776.5M$362M$414.5M
2022ended Dec 31, 2022$724M$284.6M$439.4M
2021ended Dec 31, 2021$584M$253.4M$330.6M
2020ended Dec 31, 2020$472.5M$174.4M$298.1M
2019ended Dec 31, 2019$367.2M$126.4M$240.8M
2018ended Dec 31, 2018$288.6M$104.7M$183.9M
2017ended Dec 31, 2017$263.3M$130.8M$132.5M
2016ended Dec 31, 2016$219.4M$170.2M$49.2M

Fiscal years as WEST PHARMACEUTICAL SERVICES, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on WEST PHARMACEUTICAL SERVICES, INC.

Companies of a similar size

Not investment advice. This page shows what WEST PHARMACEUTICAL SERVICES, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.